Journal of Chemistry

Journal of Chemistry / 2011 / Article

Open Access

Volume 8 |Article ID 381843 | 9 pages | https://doi.org/10.1155/2011/381843

Determination of Trace Amount of Pd(II) and Ni(II) with Newly Synthesized Pyrozlon Azo Bromo Phenol by Spectrophotometric Methods

Received01 Mar 2011
Accepted27 Apr 2011

Abstract

A sensitive and selective method has been developed for the determination of palladium(II) and nickel(II). A new reagent and two complexes have been prepared in aqueous solutions. The method is based on the chelation of metal ions with 4-(4'- antipyriyl azo ) -2-bromo phenol (APBP) to form an intense color soluble products, that are stable and have a maximum absorption at 498 nm and at 433.5 nm and εmax of 0.21×104 and.0.38×104 Lmole-1cm-1 for Pd(II) Ni(II) respectively. A linear correlation of (0.2 - 3) and (0.6 -2.2) ppm for Pd(II) Ni(II) respectively. The stoichiometry of both complexes was found to be 1:2 (metal:ligand). The effect of various cations and anions on Pd(II) and Ni(II) determination have been investigated. The stability constants Pd(II) and Ni(II) were 0.37×108, 0.38×108 L mol-1 respectively. The conductivity measurements for complexes are consistent with those expected for an electrolyte. The optimum conditions for full color development for described methods were applied satisfactorily to synthetic mixtures samples and biological samples.

Copyright © 2011 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

364 Views | 564 Downloads | 2 Citations
 PDF  Download Citation  Citation
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.